Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension - Concepedia

Concepedia

Publication | Open Access

Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension

DOI Full Paper Access

83

Citations

21

References

2021

Year

Mark Toshner, Colin Church, Lars Harbaum, Christopher J. Rhodes, Sofia S. Villar Moreschi, James Liley, R. Jones, Amit Arora, Ken Batai, Ankit A. Desai,

European Respiratory Journal

Abstract

Adverse events were consistent with the known safety profile of tocilizumab. Tocilizumab did not show any consistent treatment effect.

References

	Year	Citations

Page 1